Uso de las imágenes radiológicas en la terapia génica

1. Moss JA. Gene therapy review. Radiol Technol. 2014, Nov-Dec; 86(2): 155-80; quiz 181-4.
2. Zarante I. Terapia génica.  Revista Medicina. Agosto 2001; 23(2) 56:88-92.3. Yu Y, Annala AJ, Barrio JR, et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med, 2000; 6: 933-7.        
4. Ronchera C.L. –OMS,  González J. Mª. Terapia génica. Disponible en: http://www.sefh.es/bibliotecavirtual/fhtomo2/CAP06.pdf
5. http://www.genome.gov/GlossaryS/index.cfm?id=205
6. Catana C, Guimaraes AR, Rosen BR. PET and MRI: The odd couple or a match ade in heaven? Journal of Nuclear Medicine : official publication, Society of Nuclear Medicine, 2013; 54(5): 815-824.
7. Hyewon Youna,b and Kee-Jong Hongc. In vivo noninvasive small animal molecular imaging. Osong Public Health Res Perspect. Mar 2012; 3(1): 48-59.
8. Jacobs A, Voges J, Reszka R, et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet, 2001; 358: 727-9.        
9. Högemann-Savellano D1, Bos E, Blondet C, et al. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia. 2003, Nov-Dec; 5(6): 495-506.135.
10. Ichikawa T, Högemanny D, Saeki Y, et al. MRI of transgene expression: Correlation to therapeutic gene expression. Neoplasia (New York, N.Y.), 2002; 4(6): 523-530.
11. Zhang CY1, Lu J, Tsourkas A. Iron chelator-based amplification strategy for improved targeting of transferrin receptor with SPIO. Cancer Biol Ther. 2008, Jun; 7(6): 889-95.
12. Hingorani DV, Randtke EA, Pagel MD. A catalyCEST MRI contrast agent that detects the enzyme-catalyzed creation of a covalent bond. J. Am. Chem. Soc. 2013; 135(17): 6396-6398.
13. Benedetti S1, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med. 2000, Apr; 6(4): 447-50.
14.  Chuang K, Cheng T. Noninvasive imaging of reporter gene expression and distribution in vivo fooyin. J Health Sci. 2010; 2 (1): 1-11.
15. Mazzolini G., Sangro B., Prieto J. Evaluación in vivo de la transferencia génica. Medicina (B. Aires). 2002; 62 (4): 375-376.
16. Gambhir SS, Barrio JR, Wu L, et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J Nucl Med, 1998; 39: 2003-11.        
17. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA, 1999; 96: 2333-8.
18. Fechheimer M, Boylan JF, Parker S, et al. Transfection of mammalian cells with plasmid DNA by scrape loading and sonication loading. Proceedings of the National Academy of Sciences of the United States of America, 1987; 84(23):8463-8467.
19. Guo DP, Li XY, Sun P, et al. Ultrasound-targeted microbubble destruction improves the low density lipoprotein receptor gene expression in HepG2 cells. Biochem Biophys Res Commun. 2006, May 5; 343(2): 470-4.
20. Kaplitt MG1, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 2007, Jun 23; 369(9579): 2097-105.
21. Suh R, Goldin J, Wallace A, Ramon E, et al. Figlin metastatic renal cell carcinoma: CT-guided immunotherapy as a technically feasible and safe approach to delivery of gene therapy for treatment. Radiology. 2004, 231: 2,359-364.
22. Peñuelas I, Mazzolini G, Boán JF, et al. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology. 2005, Jun; 128(7): 1787-95.169. 
23. Jacobs A, Voges J, Reszka R, et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet, 2001; 358: 727-9.        
24. Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18, 321-325.
25. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 2000; 6: 351–355.
26. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 2005; 11: 450-454.
27. Bar-Shir A, Liu G, Greenberg MM, Bulte JW, Gilad AA. Synthesis of a probe for monitoring HSV1-TK reporter gene expression using chemical exchange saturation transfer MRI. Nat. Protoc. 2013, Dec; 8(12): 2380-91.
28. Rehemtulla A1, Hall DE, Stegman LD, et al. Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol Imaging. 2002, Jan-Mar; 1(1): 43-55.
29. Whiteman H. Brain cancer: groundbreaking MRI-guided gene therapy. Medical News Today, http://www.medicalnewstoday.com/articles/264500.php
30. Patrick PS, Hammersley J, Loizou L, et al. Dual-modality gene reporter for in vivo imaging. Proc Natl Acad Sci USA. 2014, Jan 7; 111(1): 415-20.